Gressner, Axel M.

Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets

Gressner, A. M., & Weiskirchen, R. (2006) · Journal of Cellular and Molecular Medicine

Liver physiology and pathologyTGF-β signaling in diseases

Cited by 718

Ito Cells Are Liver-Resident Antigen-Presenting Cells for Activating T Cell Responses

Winau, F., Hegasy, G., Weiskirchen, R., Weber, S., Cassan, C., Sieling, P. A., Modlin, R. L., Liblau, R. S., Gressner, A. M., & Kaufmann, S. H. E. (2007) · Immunity

Immunotherapy and Immune ResponsesT-cell and B-cell Immunology

Cited by 410

Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts

Fehrenbach, H., Weiskirchen, R., Kasper, M., & Gressner, A. M. (2001) · Hepatology

Liver physiology and pathologyAdvanced Glycation End Products research

Cited by 154

IFN-γ abrogates profibrogenic TGF-β signaling in liver by targeting expression of inhibitory and receptor Smads

Weng, H., Mertens, P. R., Gressner, A. M., & Dooley, S. (2007) · Journal of Hepatology

Liver physiology and pathologyTGF-β signaling in diseases

Cited by 152

Modulation of hepatic lipocyte proteoglycan synthesis and proliferation by Kupffer cell-derived transforming growth factors type β1 and type α

Meyer, D. H., Bachem, M. G., & Gressner, A. M. (1990) · Biochemical and Biophysical Research Communications

Liver physiology and pathologyTGF-β signaling in diseases

Cited by 106

Glucocorticoids decrease the bioavailability of TGF-β which leads to a reduced TGF-β signaling in hepatic stellate cells

Bolkenius, U., Hahn, D., Gressner, A. M., Breitkopf, K., Dooley, S., & Wickert, L. (2004) · Biochemical and Biophysical Research Communications

Liver physiology and pathologyTGF-β signaling in diseases

Cited by 54